From: Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients
Characteristics | Entire set (n = 342) |
---|---|
N (%) | |
 Age, years | |
  ≤ 60 | 141 (41.2%) |
  > 60 | 201 (58.8%) |
 Stage | |
  I | 221 (64.6%) |
  II | 31 (9.1%) |
  III | 77 (22.5%) |
  IV | 13 (3.8%) |
 Grade | |
  G1 | 80 (23.4%) |
  G2 | 74 (21.6%) |
  G3 | 188 (55.0%) |
 Peritoneal wash | |
  Negative | 293 (85.7%) |
  Positive | 49 (14.3%) |
 Person neoplasm cancer status | |
  Tumor free | 291 (85.1%) |
  With tumor | 51 (14.9%) |
 Radiation therapy | |
  Yes | 140 (40.9%) |
  No | 202 (59.1%) |
 Histological type | |
  Endometrioid endometrial adenocarcinoma | 268 (78.4%) |
  Serous endometrial adenocarcinoma | 61 (17.8%) |
  Mixed serous and endometrioid | 13 (3.8%) |
Surgical approach | |
  Minimally invasive | 150 (43.9%) |
  Open | 192 (56.1%) |